Covishield-maker Serum Institute applies to begin trials of its second COVID-19 vaccine Covovax
Covishield-maker Serum Institute applies to begin trials of its second COVID-19 vaccine Covovax: The announcement comes a day after Novovax Inc said that its Covid-19 vaccine Covovax was 89.3% effective in preventing Covid-19 in a trial conducting in the United Kingdom.(Representational image; Reuters/File Photo) Serum Institute to begin trial of second Covid-19 vaccine: Makers of … Read more